SensNews Mar 2017

27 / 31

27 Sensor100 March 2017
BloodTest used for Rapid Diagnosis of Heart Attacks in
Hospital
Elkerliek Hospital (Helmond, the Netherlands) and Royal Philips, a HealthTech com-
pany, have announced their collaboration to pioneer the use of point-of-care testing in
the hospital’s dedicated cardiac emergency department. As a key part of the collabo-
ration, Philips’ CE marked cardiac troponin I (cTnI) blood test for the rapid diagnosis
of heart attack, which is based on the company’s Minicare I-20 handheld diagnostics
platform, will be used to provide test results within 10 minutes using only a single
‘finger-prick’ drop of blood.
Based on Philips’ proprietary biosensor technology, the
Minicare I-20 handheld diagnostics platform is designed
to detect multiple target molecules at very low concen-
trations in a single ‘finger-prick’ blood sample, and display
the results on a handheld analyzer within minutes. Mini-
care I-20 is simple and easy to use by non-laboratory
staff.The analyzer’s in-built connectivity allows direct
transfer of the data to laboratory and hospital informa-
tion systems to update patient files, while integrated cali-
bration and fail-safe functionalities ensure the robustness
and accuracy needed for confident on-the-spot decision
making.
Reported by: 3 March
Wearable/disposable Sweat-based Glucose Monitoring
Device
Researchers at the Centre for Nanoparticle Research in Seoul report the electro-
chemical analysis of sweat using soft bioelectronics on human skin to provide a new
route for noninvasive glucose monitoring without painful blood collection. However,
sweat-based glucose sensing still faces many challenges, such as difficulty in sweat col-
lection, activity variation of glucose oxidase due to lactic acid secretion and ambient
temperature changes, and delamination of the enzyme when exposed to mechanical
friction and skin deformation.
8 March